tradingkey.logo
tradingkey.logo
Suchen

OptimizeRx Corp

OPRX
Zur Watchlist hinzufügen
6.190USD
+0.110+1.81%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
116.16MMarktkapitalisierung
16.76KGV TTM

mehr Informationen über OptimizeRx Corp Unternehmen

OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.

OptimizeRx Corp Informationen

BörsenkürzelOPRX
Name des UnternehmensOptimizeRx Corp
IPO-datumMay 18, 2005
CEOSilvestro (Stephen L)
Anzahl der mitarbeiter106
WertpapierartOrdinary Share
GeschäftsjahresendeMay 18
Addresse260 Charles Street
StadtWALTHAM
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl02453
Telefon12486516558
Websitehttps://www.optimizerx.com/
BörsenkürzelOPRX
IPO-datumMay 18, 2005
CEOSilvestro (Stephen L)

Führungskräfte von OptimizeRx Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
46.27K
+74.60%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
44.73K
-3.51%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
32.73K
-5.48%
Ms. Lynn O'Connor Vos
Ms. Lynn O'Connor Vos
Independent Chairperson of the Board
Independent Chairperson of the Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
423.97K
+8.14%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
106.51K
-4.90%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
81.83K
+42.18%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
72.86K
-2.50%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
68.86K
+50.12%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
66.88K
-4.03%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von OptimizeRx Corp?

Die fünf größten Anteilseigner von OptimizeRx Corp sind: Mr. James (Jim) Lang

Wie viele Institutionen halten Anteile an OptimizeRx Corp (OPRX)?

Mit Stand vom 2026Q1 halten 300 Institutionen Anteile an OptimizeRx Corp, mit einem Gesamtmarktwert von etwa 15.47M, was 82.46% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -5161941.00 gestiegen.